全文获取类型
收费全文 | 279684篇 |
免费 | 25191篇 |
国内免费 | 6055篇 |
专业分类
耳鼻咽喉 | 3785篇 |
儿科学 | 5188篇 |
妇产科学 | 4256篇 |
基础医学 | 22048篇 |
口腔科学 | 8557篇 |
临床医学 | 26467篇 |
内科学 | 27244篇 |
皮肤病学 | 2990篇 |
神经病学 | 13991篇 |
特种医学 | 7448篇 |
外国民族医学 | 15篇 |
外科学 | 27987篇 |
综合类 | 45449篇 |
现状与发展 | 11篇 |
一般理论 | 29篇 |
预防医学 | 34669篇 |
眼科学 | 6172篇 |
药学 | 28498篇 |
500篇 | |
中国医学 | 34611篇 |
肿瘤学 | 11015篇 |
出版年
2024年 | 4268篇 |
2023年 | 6704篇 |
2022年 | 10854篇 |
2021年 | 14101篇 |
2020年 | 13642篇 |
2019年 | 14502篇 |
2018年 | 12767篇 |
2017年 | 11265篇 |
2016年 | 10138篇 |
2015年 | 9489篇 |
2014年 | 18762篇 |
2013年 | 18612篇 |
2012年 | 16405篇 |
2011年 | 17948篇 |
2010年 | 14895篇 |
2009年 | 12446篇 |
2008年 | 11487篇 |
2007年 | 11632篇 |
2006年 | 10145篇 |
2005年 | 8537篇 |
2004年 | 7096篇 |
2003年 | 6170篇 |
2002年 | 4748篇 |
2001年 | 4017篇 |
2000年 | 3452篇 |
1999年 | 2868篇 |
1998年 | 2310篇 |
1997年 | 2122篇 |
1996年 | 1721篇 |
1995年 | 1706篇 |
1994年 | 1529篇 |
1993年 | 1319篇 |
1992年 | 1214篇 |
1991年 | 1119篇 |
1990年 | 950篇 |
1989年 | 935篇 |
1988年 | 879篇 |
1987年 | 773篇 |
1986年 | 726篇 |
1985年 | 2148篇 |
1984年 | 2428篇 |
1983年 | 1563篇 |
1982年 | 2027篇 |
1981年 | 1483篇 |
1980年 | 1320篇 |
1979年 | 1179篇 |
1978年 | 973篇 |
1977年 | 758篇 |
1976年 | 849篇 |
1975年 | 566篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
《Journal of cystic fibrosis》2022,21(6):908-921
This paper is the first in a series providing updated guidance on the definition, evaluation and management of people with a Cystic Fibrosis Transmembrane conductance Regulator (CFTR)-Related Disorder (CFTR-RD). The need for this update relates to more precise characterisation of CFTR gene variants and improved assessment of CFTR protein dysfunction. The exercise is co-ordinated by the European CF Society Standards of Care Committee and Diagnostic Network Working Group and involves stakeholder engagement. This first paper was produced by a core group using an extensive literature review and papers graded for their quality. Subsequent wider stakeholder agreement was achieved.The definition of a CFTR-RD remains “a clinical condition with evidence of CFTR protein dysfunction that does not fulfil the diagnostic criteria for CF”. Clearer guidance on CFTR dysfunction and relevant CFTR variants will be provided. Thresholds for clinical presentations are presented and the paradigm that pathobiological processes may be evident in more than one organ is agreed. In this paper we reflect on the early patient journey, highlighting that CF specialists as well as other relevant specialists should be involved in the care of people with a CFTR-RD. 相似文献
3.
《Dental materials》2022,38(6):924-934
ObjectivesTo study the oxide layer stability of certified dental implants of system "P", made based on TiO2 alloy with carbon coating. To perform a comparative statistical analysis of the obtained data with the available data for the dental implants of systems "A" and "B".MethodsX-ray microtomography and X-ray fluorescence analysis were used to study soft tissue biopsy specimens. Supernatants were studied by dynamic light scattering and transmission electron microscopy when simulating free emission of nanoscale metal oxide particles from the surface of dental implants as well as when simulating physical loading. A comparative analysis of three parameters of nanoscale particles was performed by statistical data analysis. The surface of the "P" system dental implant with surface treatment was analyzed by scanning electron microscopy.ResultsBoth free emission of nanoscale oxide layer particles and yield of nano- and microscale particles during simulation of physical load were confirmed. Statistically significant differences were noted in a comparative analysis of the size and frequency of occurrence of these particles in the supernatants obtained from the surfaces of three dental implant systems. The elemental composition of the particles and the composition and structure of the "P" system dental implants themselves were analyzed.SignificanceThe developed method of dynamic light scattering can be used to compare the stability of the oxide layer of standardized medical products manufactured on the basis of the TiO2 alloy. 相似文献
4.
《Neuro-Chirurgie》2023,69(5):101478
ObjectivePituitary abscess is an often misdiagnosed, rare clinical disorder. To improve diagnostic accuracy and the efficacy of surgical and antibiotic therapy for patients with pituitary abscess, herein, we retrospectively reviewed 15 patients who presented with pituitary abscesses from 2005 to 2022.DesignRetrospective study.PatientsFifteen patients underwent transsphenoidal surgery and received antibiotic treatment.MeasurementsComplete details regarding medical history, clinical manifestations, laboratory examinations, imaging studies, and treatment strategies were obtained for all patients.ResultsMost patients presented with hypopituitarism and headaches, while some presented with fever, visual disturbances, and diabetes insipidus (DI). Abscesses showed significant annular enhancement post gadolinium injection. In most patients, pituitary abscess can be cured via microscopic or endoscopic drainage of the abscess followed by antibiotic treatment. Complete cure of pituitary abscess was observed in nine patients, with six cases of prolonged hypopituitarism and only one case of recurrence. Long-term hormone replacement therapy was effective in the postoperative management of hypopituitarism.ConclusionsThe typical manifestations of pituitary abscess include hypopituitarism and headaches; the presence of an enhanced ring at the edge of the mass on contrast-enhanced magnetic resonance images (MRI) is highly suggestive of pituitary abscess. We recommend antibiotic treatment for 4–6 weeks postoperatively, based on the results of bacterial cultures or metagenomic next-generation sequencing (mNGS). 相似文献
5.
6.
7.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(4):230-240
AimsCurrent follow-up for head and neck cancer (HNC) is ineffective, expensive and fails to address patients' needs. The PETNECK2 trial will compare a new model of patient-initiated follow-up (PIFU) with routine scheduled follow-up. This article reports UK clinicians' views about HNC follow-up and PIFU, to inform the trial design.Materials and methodsOnline focus groups with surgeons (ear, nose and throat/maxillofacial), oncologists, clinical nurse specialists and allied health professionals. Clinicians were recruited from professional bodies, mailing lists and personal contacts. Focus groups explored views on current follow-up and acceptability of the proposed PIFU intervention and randomised controlled trial design (presented by the study co-chief investigator), preferences, margins of equipoise, potential organisational barriers and thoughts about the content and format of PIFU. Data were interpreted using inductive thematic analysis.ResultsEight focus groups with 34 clinicians were conducted. Clinicians highlighted already known limitations with HNC follow-up – lack of flexibility to address the wide-ranging needs of HNC patients, expense and lack of evidence – and agreed that follow-up needs to change. They were enthusiastic about the PETNECK2 trial to develop and evaluate PIFU but had concerns that PIFU may not suit disengaged patients and may aggravate patient anxiety/fear of recurrence and delay detection of recurrence. Anticipated issues with implementation included ensuring a reliable route back to clinic and workload burden on nurses and allied health professionals.ConclusionsClinicians supported the evaluation of PIFU but voiced concerns about barriers to help-seeking. An emphasis on patient engagement, psychosocial issues, symptom reporting and reliable, quick routes back to clinic will be important. Certain patient groups may be less suited to PIFU, which will be evaluated in the trial. Early, meaningful, ongoing engagement with clinical teams and managers around the trial rationale and recruitment process will be important to discourage selective recruitment and address risk-averse behaviour and potential workload burden. 相似文献
8.
目的:探讨尿酸性肾病中医分型与氧化应激相关性。方法:采用回顾性分析方法对2017年12月至2019年9月北京中医药大学第三附属医院收治的尿酸性肾病患者105例进行研究,选择同时期正常健康者105例作为对照,参考《中药新药临床研究指导原则》将105例尿酸性肾病和临床常见证型相结合,分成脾肾气虚18例、气阴两虚证19例、肝肾阴虚16例、阴阳两虚12例、湿热蕴结19例、瘀血阻滞17例、痰浊内阻13例,均在入院次日清晨空腹抽取静脉血,检测氧化应激氧化应激、肾功能损害指标,比较不同组别在氧化应激指标含量水平变化情况,比较中医分型和氧化应激、肾功能损害指标水平变化。结果:1)尿酸性肾病组总抗氧化能力(T-ACO)、晚期蛋白氧化物(AOPP)、血清丙二醇(MDA)、超氧化物歧化酶(SOD)含量水平分别为(19.45±3.42)U/mL、(42.45±3.53)μmol/L、(4.52±1.23)nmol/L、(76.78±5.64)U/mL,正常对照组则分别为(10.76±1.31)U/mL、(20.84±1.28)μmol/L、(2.13±0.76)nmol/L、(130.85±16.75)U/mL,尿酸性肾病组T-ACO、AOPP、MDA较正常对照组显著偏高,SOD显著偏低(P<0.05)。2)虚证中阴阳两虚证SOD含量上较其他证型均偏低,而MDA、T-AOC、AOPP、胱抑素C(CysC)、β2微球蛋白、尿微量白蛋白(UMALB)、蛋白尿发生率则较其他证型均偏高,差异均有统计学意义(P<0.05),实证中瘀血阻滞证SOD含量较其他证型均偏低,而MDA、T-AOC、AOPP则较其他证型均偏高,差异均有统计学意义(P<0.05)。结论:尿酸性肾病中医分型的阴阳两虚证、瘀血阻滞证氧化应激水平、肾损害指标均显著升高,可结合该实验室检查进行临床干预。 相似文献
9.
Watanachai Klankluang Panate Pukrittayakamee Wanlop Atsariyasing Arunotai Siriussawakul Pratamaporn Chanthong Sasima Tongsai Supakarn Tayjasanant 《The oncologist》2020,25(2):e335-e340
Background
Delirium, a neuropsychiatric syndrome that occurs throughout medical illness trajectories, is frequently misdiagnosed. The Memorial Delirium Assessment Scale (MDAS) is a commonly used tool in palliative care (PC) settings. Our objective was to establish and validate the Memorial Delirium Assessment Scale-Thai version (MDAS-T) in PC patients.Materials and Methods
The MDAS was translated into Thai. Content validity, inter-rater reliability, and internal consistency were explored. The construct validity of the MDAS-T was analyzed using exploratory factor analysis. Instrument testing of the MDAS-T, the Thai version of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU-T), and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition as the gold standard was performed. The receiver operating characteristic (ROC) curve was used to determine the optimal cutoff score. The duration of each assessment was recorded.Results
The study enrolled 194 patients. The content validity index was 0.97. The intraclass correlation coefficient and Cronbach's α coefficient were 0.98 and 0.96, respectively. A principal component analysis indicated a homogeneous, one-factor structure. The area under the ROC curve was 0.96 (95% confidence interval [CI], 0.93–0.99). The best combination of sensitivity and specificity (95% CI) of the MDAS-T were 0.92 (0.85–0.96) and 0.90 (0.82–0.94), respectively, with a cutoff score of 9, whereas the CAM-ICU-T yielded 0.58 (0.48–0.67) and 0.98 (0.93–0.99), respectively. The median MDAS-T assessment time was 5 minutes.Conclusion
This study established and validated the MDAS-T as a good and feasible tool for delirium screening and severity rating in PC settings.Implications for Practice
Delirium is prevalent in palliative care (PC) settings and causes distress to patients and families, thereby making delirium screening necessary. This study found that the MDAS-T is a highly objective and feasible test for delirium screening and severity monitoring in PC settings and can greatly improve the quality of care for this population.10.
周庭源 《中国继续医学教育》2020,(14):174-176
目的分析急性上消化道出血患者采用康复新液联合消化内镜治疗的临床疗效。方法将2017年1月-2019年8月在本院接受治疗的42例急性上消化道出血患者纳入本次研究,根据不同的止血方法进行分组:对照组(n=21)采用消化内镜治疗;观察组(n=21)采用康复新液联合消化内镜治疗,比较治疗效果。结果 (1)临床疗效:观察组中,显效13例、有效7例、无效1例,总有效率95.24%;对照组中,显效9例、有效9例、无效3例,总有效率85.71%,差异不具有统计学意义(P> 0.05)。(2)并发症发生率:观察组出现再出血1例、发热1例,发生率9.52%;对照组中,再出血3例、发热3例、穿孔2例,发生率38.10%。差异具有统计学意义(P <0.05)。差异具有统计学意义(P <0.05)。结论康复新液联合消化内镜治疗在急性上消化道出血的治疗中具有良好的应用效果,适合在临床中应用。 相似文献